Detalhe da pesquisa
1.
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
Haematologica
; 104(1): 138-146, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171024
2.
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.
Haematologica
; 95(8): 1350-7, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20220059
3.
Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
Haematologica
; 90(6): 802-9, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15951293